financetom
Business
financetom
/
Business
/
--Adobe OKs New Stock Buyback of Up to $25 Billion in Shares
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Adobe OKs New Stock Buyback of Up to $25 Billion in Shares
Mar 14, 2024 1:35 PM

04:10 PM EDT, 03/14/2024 (MT Newswires) --

Price: 533.2, Change: -37.25, Percent Change: -6.53

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tonix Pharmaceuticals Plans Stock Offering; Shares Fall After-Hours
Tonix Pharmaceuticals Plans Stock Offering; Shares Fall After-Hours
Jul 8, 2024
05:18 PM EDT, 07/08/2024 (MT Newswires) -- Tonix Pharmaceuticals ( TNXP ) said late Monday it plans to sell an undisclosed amount of its shares in a public offering, with Dawson James Securities as its placement agent. The company said it intends to use the net proceeds for working capital and general corporate purposes. Tonix shares were down about 20%...
--Ellington Financial Maintains Monthly Dividend at $0.13 Per Share, Payable Aug. 26 to Stockholders of Record July 31
--Ellington Financial Maintains Monthly Dividend at $0.13 Per Share, Payable Aug. 26 to Stockholders of Record July 31
Jul 8, 2024
05:14 PM EDT, 07/08/2024 (MT Newswires) -- Price: 12.28, Change: -0.01, Percent Change: -0.08 ...
Rupert Resources Unable to Reach Terms to Acquire 100% of the Fingold Joint Venture
Rupert Resources Unable to Reach Terms to Acquire 100% of the Fingold Joint Venture
Jul 8, 2024
05:15 PM EDT, 07/08/2024 (MT Newswires) -- Rupert Resources ( RUPRF ) after trade Monday said it has been unable to reach acceptable terms to acquire the full 100% of the Fingold joint venture to consolidate further exploration licenses near its Ikkari Project in Finland. A statement noted Fingold is a joint venture held 70% by B2Gold ( BTG )...
Kymera Reports Expansion of KT-474 Trials; Shares Rise After-Hours
Kymera Reports Expansion of KT-474 Trials; Shares Rise After-Hours
Jul 8, 2024
05:14 PM EDT, 07/08/2024 (MT Newswires) -- Kymera Therapeutics ( KYMR ) said Monday Sanofi (SNY) has informed the company over its plan to expand the ongoing Hidradenitis Suppurativa and Atopic Dermatitis mid-stage trials to more rapidly progress towards pivotal studies. Kymera said the expansion followed a review of preliminary KT-474 data by an Independent Data Review Committee. This expansion,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved